MedPath

Enpresse

ENPRESSE™ – 28 TABLETS(levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)

Approved
Approval ID

6c095eec-8d92-4b07-8f9e-84bb8c9bc3f8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 26, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

levonorgestrel and ethinyl estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-855
Application NumberANDA075809
Product Classification
M
Marketing Category
C73584
G
Generic Name
levonorgestrel and ethinyl estradiol
Product Specifications
Effective DateDecember 20, 2010
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Enpresse - FDA Drug Approval Details